Discover promising genetic sequencing stocks and stay ahead in the genomics revolution. Learn which companies are driving DNA technology forward.

An AI framework has been developed that analyzes multiple signals in cell-free DNA to detect cancer from blood samples. Using ...

For researchers on the hunt for the genetic roots of disease, the cost of deep whole-genome sequencing makes it challenging ...

Strand Life Sciences secures Indian patent for early cancer detection platform using cfDNA analysis from a single blood ...

Scientists have created a silicon chip that can write dozens of DNA sequences simultaneously using electricity and ...

Just over two decades ago, reading the complete human genome was considered one of the most ambitious scientific projects ever attempted. The international Human Genome Project took nearly 13 years ...

As genome editing therapies move through clinical trials to regulatory approval, scientists continue the quest for the holy ...

Genome-wide association studies (GWAS) have catalogued hundreds of thousands of genetic variants linked to complex human traits and diseases, with more than 625,000 variant-trait associations across ...

In the study of bacteria, a longstanding dogma has held that two molecular machines—RNA polymerase, which leads the way in transcribing DNA into RNA, and ribosomes, which bring up the rear translating ...

We spoke to David Klenerman, co-developer of sequencing by synthesis, to find out how his work heralded the next generation ...

Roche launched its next-generation gene sequencing machine on Monday, marking a bid by the Swiss drugmaker and diagnostics group to loosen U.S.-based Illumina's grip on genetic-testing and research ...

By Bhanvi Satija and Marleen Kaesebier LONDON/ZURICH, June 29 (Reuters) - Swiss pharmaceutical and diagnostics giant Roche launched its long-awaited Axelios gene sequencer on Monday, in a bid to ...